Lingzhi Hong, Jianjun Zhang, John V Heymach, Xiuning Le. Ther Adv Med Oncol 2021
Times Cited: 21
Times Cited: 21
Mark A Socinski, Nathan A Pennell, Kurtis D Davies. JCO Precis Oncol 2021
Times Cited: 24
Times Cited: 24
List of shared articles
Times cited
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Michael Schumacher, Elizabeth Dudnik, Michael Studnicka, Ronny Öhman, Robert Wurm,[...]. Ther Adv Med Oncol 2022
Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Michael Schumacher, Elizabeth Dudnik, Michael Studnicka, Ronny Öhman, Robert Wurm,[...]. Ther Adv Med Oncol 2022
Landscape of Savolitinib Development for the Treatment of Non-Small Cell Lung Cancer with MET Alteration-A Narrative Review.
Xiaokuan Zhu, Yao Lu, Shun Lu. Cancers (Basel) 2022
Xiaokuan Zhu, Yao Lu, Shun Lu. Cancers (Basel) 2022
Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models.
Yunhua Xu, Linping Gu, Yingqi Li, Ruiying Zhao, Hong Jian, Wenhui Xie, Liu Liu, Huiwen Wu, Fang Ren, Yuchen Han,[...]. Front Oncol 2022
Yunhua Xu, Linping Gu, Yingqi Li, Ruiying Zhao, Hong Jian, Wenhui Xie, Liu Liu, Huiwen Wu, Fang Ren, Yuchen Han,[...]. Front Oncol 2022
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.
Juan Esteban Garcia-Robledo, Rafael Rosell, Alejandro Ruíz-Patiño, Carolina Sotelo, Oscar Arrieta, Lucia Zatarain-Barrón, Camila Ordoñez, Elvira Jaller, Leonardo Rojas, Alessandro Russo,[...]. Ther Adv Respir Dis 2022
Juan Esteban Garcia-Robledo, Rafael Rosell, Alejandro Ruíz-Patiño, Carolina Sotelo, Oscar Arrieta, Lucia Zatarain-Barrón, Camila Ordoñez, Elvira Jaller, Leonardo Rojas, Alessandro Russo,[...]. Ther Adv Respir Dis 2022
Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations.
Paul K Paik, Boris M Pfeiffer, Helene Vioix, Andrea Garcia, Maarten J Postma. Adv Ther 2022
Paul K Paik, Boris M Pfeiffer, Helene Vioix, Andrea Garcia, Maarten J Postma. Adv Ther 2022
New Targeted Therapy for Non-Small Cell Lung Cancer.
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee. Tuberc Respir Dis (Seoul) 2023
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee. Tuberc Respir Dis (Seoul) 2023
Clinical and pathological characteristics of 11 NSCLC patients with c-MET exon 14 skipping.
Hualin Chen, Yipin Luo, Muwen Lin, Huoguang Chen, Meilian Liu, Yongcun Wang, Shujun Li, Donghong Yang, Zhixiong Yang. Transl Cancer Res 2022
Hualin Chen, Yipin Luo, Muwen Lin, Huoguang Chen, Meilian Liu, Yongcun Wang, Shujun Li, Donghong Yang, Zhixiong Yang. Transl Cancer Res 2022